Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“This is a step in the right direction, but more work needs to be done.”
A study finds that CD4 cells decline after people with HIV contract hepatitis C.
But health officials believe the risk of infection from improperly sterilized equipment is low.
In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.
But the health secretary does not support safe injection sites.
The Bad River and Red Cliff bands in Wisconsin operate lifesaving syringe access programs.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
For over 30 years, the California-based group fought for treatments, research, education and quality health care.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
These two men both recently discovered that they had hepatitis C, each with a different story about their encounters with insurance.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Hepatitis C increases risk of death among people on HIV treatment.
This is according to the large randomized controlled START trial.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
And, says Miss Ian, they reduce new HIV and hepatitis C transmissions.
Was the “Jackass” star at risk of contracting HIV? Plus: the other link between HIV and cocaine.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.